The following pages link to etomidate (Q418445):

Displaying 50 items.

• pain (Q81938) (← links)
• status epilepticus (Q980709) (← links)
• brain ischemia (Q4862390) (← links)
• closed head injury (Q5135341) (← links)
• Single-Dose Etomidate Does Not Increase Mortality in Patients With Sepsis (Q22306059) (← links)
• Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients (Q24186699) (← links)
• Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients (Q24197787) (← links)
• One single dose of etomidate negatively influences adrenocortical performance for at least 24h in children with meningococcal sepsis (Q24642816) (← links)
• The interaction of the general anesthetic etomidate with the γ-aminobutyric acid type A receptor is influenced by a single amino acid (Q24654417) (← links)
• Effect of propofol and etomidate on normoxic and chronically hypoxic pulmonary artery (Q25257894) (← links)
• Etomidate in pediatric anesthesiology: Where are we now? (Q26778878) (← links)
• 3-[(1S)-1-phenylethyl]-4-imidazolecarboxylic acid ethyl ester (Q27167116) (← links)
• The safety of etomidate for emergency rapid sequence intubation of pediatric patients (Q28145686) (← links)
• Etomidate for procedural sedation in emergency medicine (Q28218690) (← links)
• A review of etomidate for rapid sequence intubation in the emergency department (Q28235144) (← links)
• A review of etomidate for rapid sequence intubation in the emergency department (Q28237681) (← links)
• Etomidate for endotracheal intubation in sepsis: acknowledging the good while accepting the bad (Q28239528) (← links)
• Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: a critical appraisal (Q28239549) (← links)
• Cerebral function under etomidate, a new non-barbiturate i.v. hypnotic (author's transl) (Q28243256) (← links)
• Etomidate, a new water-soluble non-barbiturate intravenous induction agent (Q28245848) (← links)
• Distinct actions of etomidate and propofol at beta3-containing gamma-aminobutyric acid type A receptors (Q28249934) (← links)
• Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial (Q28250685) (← links)
• The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock (Q28253821) (← links)
• Mapping general anesthetic binding site(s) in human α1β3 γ-aminobutyric acid type A receptors with [³H]TDBzl-etomidate, a photoreactive etomidate analogue (Q28257428) (← links)
• Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality (Q28258746) (← links)
• Intracarotid amobarbital procedure and etomidate speech and memory test (Q28258887) (← links)
• Etomidate: a selective adrenocortical 11 beta-hydroxylase inhibitor (Q28259659) (← links)
• Duration of adrenal inhibition following a single dose of etomidate in critically ill patients (Q28261624) (← links)
• Etomidate for emergency anaesthesia; mad, bad and dangerous to know? (Q28262634) (← links)
• Etomidate and other non-barbiturates (Q28263636) (← links)
• Randomized clinical trial of etomidate versus propofol for procedural sedation in the emergency department (Q28265160) (← links)
• Etomidate versus midazolam for procedural sedation in pediatric outpatients: a randomized controlled trial (Q28265224) (← links)
• Inhibition of Adrenal Steroidogenesis by the Anesthetic Etomidate (Q28265969) (← links)
• Stereoselective effects of etomidate optical isomers on gamma-aminobutyric acid type A receptors and animals (Q28266232) (← links)
• Propanidid and etomidate identification from the blood by thin-layer chromatography (Q28266545) (← links)
• Adrenal inhibition following a single dose of etomidate in intubated traumatic brain injury victims (Q28274861) (← links)
• The effect of a bolus dose of etomidate on cortisol levels, mortality, and health services utilization: a systematic review (Q28277908) (← links)
• Etomidate: not worth the risk in septic patients (Q28284444) (← links)
• Etomidate speech and memory test (eSAM): a new drug and improved intracarotid procedure (Q28286436) (← links)
• Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study (Q28301508) (← links)
• Anesthetic induction with etomidate, rather than propofol, is associated with increased 30-day mortality and cardiovascular morbidity after noncardiac surgery (Q28302342) (← links)
• A prospective observational study of the effect of etomidate on septic patient mortality and length of stay (Q28302816) (← links)
• Respiratory effects of etomidate (Q28316811) (← links)
• Sympathetic responses to induction of anesthesia in humans with propofol or etomidate (Q28319694) (← links)
• Etomidate in a new solvent. A clinical evaluation (Q28324316) (← links)
• Comparison of etomidate in combination with fentanyl or diazepam, with thiopentone as an induction agent for general anaesthesia (Q28328866) (← links)
• Effect of premedication on etomidate anaesthesia (Q28328867) (← links)
• The modification of injection pain and the incidence of thrombophlebitis following etomidate (Q28330852) (← links)
• Anesthesia for cardioversion. A comparison of propofol and etomidate (Q28331284) (← links)
• Etomidate using a new solubilizer. Experimental clinical studies on venous tolerance and bioavailability (Q28332640) (← links)